Enlarge this image Mylan CEO Heather Bresch defended pricing for the company’s EpiPen on Capitol Hill in September. Pablo Martinez Monsivais/AP hide…
Topics
generic drugs
-
-
Enlarge this image In an emailed statement, Mylan told NPR, “To date, we know of no evidence that Mylan participated in price…
-
Enlarge this image Generic drugmaker Mylan is one of the companies reported to be the subject of a Justice Department investigation into…
-
Enlarge this image A patient with Crohn’s disease receives an IV infusion of Remicade, or infliximab. Dr P. Marazzi/Science Source hide caption…